For the quarter ending 2026-01-31, ENGNW had -$13,539K decrease in cash & cash equivalents over the period. -$29,056K in free cash flow.
| Cash Flow | 2026-01-31 | 2025-10-31 | 2025-07-31 |
|---|---|---|---|
| Net loss | -29,752 | -37,880 | -79,422 |
| Non-cash interest expense | 183 | 209 | 645 |
| Loss on extinguishment of debt | -488 | - | - |
| Non-cash lease expense | -246 | -253 | -125 |
| Net amortization of premiums (accretion of discounts) on marketable securities | - | -3,067 | - |
| Accretion of marketable securities | -2,054 | - | 2,645 |
| Unrealized foreign currency losses | -69 | 25 | -28 |
| Share-based compensation expense | 2,803 | 2,606 | 7,040 |
| Depreciation of property and equipment | 189 | 171 | 338 |
| Investment tax credit receivable | 271 | 217 | 378 |
| Prepaid expenses and other assets | 2,422 | -1,986 | -3 |
| Accounts payable | -4,270 | 3,972 | 970 |
| Accrued expenses and other current liabilities | 4,386 | 4,154 | -1,024 |
| Lease liabilities | 39 | 231 | 43 |
| Net cash used in operating activities | -28,903 | -24,962 | -74,277 |
| Purchases of property and equipment | 153 | 437 | 1,048 |
| Purchases of marketable securities | 169,187 | 7,748 | 153,095 |
| Proceeds from maturities of marketable securities | 43,043 | 48,685 | 88,505 |
| Net cash used in investing activities | -126,297 | 40,500 | -65,638 |
| Proceeds from second amended term loan | 25,000 | - | - |
| Repayment of amended term loan principal | 23,053 | 0 | 699 |
| Payment of issuance costs associated with second amended term loan | 615 | - | - |
| Proceeds from issuance of pre-funded warrants | 23,249 | - | - |
| Proceeds from public offering | 126,250 | - | - |
| Payment of issuance cost associated with public offering and pre-funded warrants | 9,448 | - | - |
| Proceeds from exercise of stock options | 277 | 1,991 | 232 |
| Net cash provided by financing activities | 141,660 | 1,991 | -467 |
| Effect of exchange rate changes on cash | 1 | 0 | 1 |
| Net decrease in cash and cash equivalents | -13,539 | 17,529 | -140,381 |
| Cash and cash equivalents at beginning of period | 50,152 | 173,004 | - |
| Cash and cash equivalents at end of period | 36,613 | 50,152 | - |
enGene Holdings Inc. (ENGNW)
enGene Holdings Inc. (ENGNW)